HR 3

The International Pricing Index Has Some Flaws

The International Pricing Index (IPI) piece included in Speaker Pelosi's Lower Drug Costs Now Act may seem like the perfect solution to bringing down the price of expensive prescription drugs, but there are some real problems with this model. IPI can potentially hurt the most vulnerable and sick patients when they're at their worst, and take away their ability to get access to treatments. The model would base the price the US pays for prescription drugs off of what six other countries pay.

Subscribe to RSS - HR 3